BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 38537978)

  • 1. Tailoring Radiation Therapy for Patients With Limited Cutaneous T Cell Lymphoma: Preliminary Clinical Experience With Subtotal Skin Electron Therapy.
    Laughlin BS; Zaniletti I; Foster MG; Lucido J; Mangold AR; Rosenthal AC; VAN DER Walt C; Breen W; Lester S; Hoppe B; Petersen J; Armstrong MD; Bogan A; Rule WG
    Anticancer Res; 2024 Apr; 44(4):1491-1497. PubMed ID: 38537978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Palliative total skin electron beam therapy (TSEBT) for advanced cutaneous T-cell lymphoma.
    Funk A; Hensley F; Krempien R; Neuhof D; Van Kampen M; Treiber M; Roeder F; Timke C; Herfarth K; Helmbold P; Debus J; Bischof M
    Eur J Dermatol; 2008; 18(3):308-12. PubMed ID: 18474461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Total skin electron beam therapy followed by adjuvant psoralen/ultraviolet-A light in the management of patients with T1 and T2 cutaneous T-cell lymphoma (mycosis fungoides).
    Quirós PA; Jones GW; Kacinski BM; Braverman IM; Heald PW; Edelson RL; Wilson LD
    Int J Radiat Oncol Biol Phys; 1997 Jul; 38(5):1027-35. PubMed ID: 9276369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient perspectives regarding the value of total skin electron beam therapy for cutaneous T-cell lymphoma/mycosis fungoides: a pilot study.
    Yu JB; Khan AM; Jones GW; Reavely MM; Wilson LD
    Am J Clin Oncol; 2009 Apr; 32(2):142-4. PubMed ID: 19307950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic chemotherapy and extracorporeal photochemotherapy for T3 and T4 cutaneous T-cell lymphoma patients who have achieved a complete response to total skin electron beam therapy.
    Wilson LD; Licata AL; Braverman IM; Edelson RL; Heald PW; Feldman AM; Kacinski BM
    Int J Radiat Oncol Biol Phys; 1995 Jul; 32(4):987-95. PubMed ID: 7607973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dose (10-Gy) total skin electron beam therapy for cutaneous T-cell lymphoma: an open clinical study and pooled data analysis.
    Kamstrup MR; Gniadecki R; Iversen L; Skov L; Petersen PM; Loft A; Specht L
    Int J Radiat Oncol Biol Phys; 2015 May; 92(1):138-43. PubMed ID: 25863761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-dose total skin electron beam therapy as an effective modality to reduce disease burden in patients with mycosis fungoides: results of a pooled analysis from 3 phase-II clinical trials.
    Hoppe RT; Harrison C; Tavallaee M; Bashey S; Sundram U; Li S; Million L; Dabaja B; Gangar P; Duvic M; Kim YH
    J Am Acad Dermatol; 2015 Feb; 72(2):286-92. PubMed ID: 25476993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Total skin electron beam therapy for cutaneous T-cell lymphoma: a nationwide cohort study from Denmark.
    Lindahl LM; Kamstrup MR; Petersen PM; Wirén J; Fenger-Grøn M; Gniadecki R; Iversen L; Specht L
    Acta Oncol; 2011 Nov; 50(8):1199-205. PubMed ID: 21736502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-dose total skin electron beam therapy plus oral bexarotene maintenance therapy for cutaneous T-cell lymphoma.
    Elsayad K; Rolf D; Sunderkötter C; Weishaupt C; Müller EC; Nawar T; Stranzenbach R; Livingstone E; Stadler R; Steinbrink K; Moritz RKC; Eich HT
    J Dtsch Dermatol Ges; 2022 Mar; 20(3):279-285. PubMed ID: 34984837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-dose total skin electron beam therapy as a debulking agent for cutaneous T-cell lymphoma: an open-label prospective phase II study.
    Kamstrup MR; Lindahl LM; Gniadecki R; Iversen L; Skov L; Petersen PM; Loft A; Specht L
    Br J Dermatol; 2012 Feb; 166(2):399-404. PubMed ID: 21967035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute and sub-acute toxicity profile of ultra-hypofractionated low-dose total skin electron beam with two 4 Gy fractions for cutaneous T cell lymphoma.
    Rolf D; Elsayad K; Eich HT
    J Cancer Res Clin Oncol; 2021 Jun; 147(6):1757-1761. PubMed ID: 33219856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Total skin electron beam therapy with or without adjuvant topical nitrogen mustard or nitrogen mustard alone as initial treatment of T2 and T3 mycosis fungoides.
    Chinn DM; Chow S; Kim YH; Hoppe RT
    Int J Radiat Oncol Biol Phys; 1999 Mar; 43(5):951-8. PubMed ID: 10192339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Additional courses of total skin electron beam therapy in the treatment of patients with recurrent cutaneous T-cell lymphoma.
    Wilson LD; Quiros PA; Kolenik SA; Heald PW; Braverman IM; Edelson RL; Kacinski BM
    J Am Acad Dermatol; 1996 Jul; 35(1):69-73. PubMed ID: 8682967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extent of skin involvement as a prognostic indicator of disease free and overall survival of patients with T3 cutaneous T-cell lymphoma treated with total skin electron beam radiation therapy.
    Quiros PA; Kacinski BM; Wilson LD
    Cancer; 1996 May; 77(9):1912-7. PubMed ID: 8646693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Long term results of total skin electron beam therapy (TSEBT) in the treatment of mycosis fungoides].
    Hagedorn M; Hasche E; Kober B; Sander CA
    Hautarzt; 2003 Mar; 54(3):256-64. PubMed ID: 12634995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective cohort study of condensed low-dose total skin electron beam therapy for mycosis fungoides: Reduction of disease burden and improvement in quality of life.
    Song A; Gochoco A; Zhan T; Sahu J; Alpdogan O; Porcu P; Nikbakht N; Shi W
    J Am Acad Dermatol; 2020 Jul; 83(1):78-85. PubMed ID: 32004646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ultimate results of radiation therapy for T1-T2 mycosis fungoides (including reirradiation).
    Ysebaert L; Truc G; Dalac S; Lambert D; Petrella T; Barillot I; Naudy S; Horiot JC; Maingon P
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1128-34. PubMed ID: 15001254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-dose total skin electron beam therapy for cutaneous lymphoma : Minimal risk of acute toxicities.
    Kroeger K; Elsayad K; Moustakis C; Haverkamp U; Eich HT
    Strahlenther Onkol; 2017 Dec; 193(12):1024-1030. PubMed ID: 28785772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute toxicity and risk of infection during total skin electron beam therapy for mycosis fungoides.
    Lloyd S; Chen Z; Foss FM; Girardi M; Wilson LD
    J Am Acad Dermatol; 2013 Oct; 69(4):537-43. PubMed ID: 23849563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Total Skin Electron Beam Therapy as Part of Multimodal Treatment Strategies for Primary Cutaneous T-Cell Lymphoma.
    Elsayad K; Susek KH; Eich HT
    Oncol Res Treat; 2017; 40(5):244-252. PubMed ID: 28448985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.